Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review

The inclusion of patient-reported outcome (PRO) measures in chimeric antigen receptor (CAR) T-cell therapy research is critical for understanding the impact of this novel approach from a unique patient standpoint. We performed a scoping review to map the available literature on the use of PRO measur...

Full description

Bibliographic Details
Main Authors: Fabio Efficace, Laura Cannella, Francesco Sparano, Johannes M. Giesinger, Marco Vignetti, Frédéric Baron, Eduardo Bruera, Mario Luppi, Uwe Platzbecker
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000802

Similar Items

Similar Items